Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 0.06 (3.33%) Market Cap: 506.90 Mil Enterprise Value: 908.43 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 62/100

Q3 2022 Pacific Biosciences of California Inc Earnings Call Transcript

Nov 07, 2022 / 10:00PM GMT
Release Date Price: $8.42 (+2.06%)
Operator

Hello, and welcome to the PacBio Third Quarter Fiscal Year 2022 Financial Results Conference Call. (Operator Instructions). I would now like to turn the conference over to Todd Friedman, Director of Investor Relations. Please go ahead.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

Good afternoon, and welcome to PacBio's Third Quarter 2022 Earnings Conference Call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call. A copy of which is available on the Investors section of our website at www.pacb.com, or as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. With me today are Christian Henry, President and Chief Executive Officer; and Susan Kim, Chief Financial Officer.

Before we begin, I'd like to remind you that on today's call, we will be making forward-looking statements, including statements regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot